Unibest
← Back to patent-cliff list

CAS 38385-95-4

2-(piperidin-4-yl)-1H-benzo[d]imidazole

Codes: BALI-001, BALI-007

Application context (from source-drug indications)

UrticariaBilastineAllergic rhinitisBilastineDermatitisBilastinePruritusBilastineEczemaBilastineAllergic conjunctivitisBilastine

Source drugs (routes using this intermediate)

DrugTierExpiry
BilastineTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

BilastineOriginator routesteps: 3total yield: 3.5 g
2-(piperidin-4-yl)-1H-benzo[d]imidazole→4-(2-(4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl 4-methylbenzenesulfonate→2-(2-(4-(2-(4-(1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,5-dihydrooxazole→2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,5-dihydrooxazole

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Site2-Piperidin-4-yl-1H-benzoimidazole
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.